首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1922659

日本免疫组织化学市场报告：按产品、应用、最终用户和地区划分（2026-2034年）

Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本免疫组织化学市场规模达1.885亿美元。 IMARC集团预测，到2034年，该市场规模将达到3.226亿美元，2026年至2034年的复合年增长率（CAGR）为6.15%。推动市场成长的关键因素包括：与老龄化相关的疾病增加、完善的医疗基础设施、个人化医疗意识的提高、政府对医学研究投入和支持的增加，以及病理学领域的最新进展。

免疫组织化学 (IHC) 是一种诊断和研究技术，它利用抗原-抗体相互作用的原理来识别组织样本中的特定蛋白质、抗原或细胞。将抗体应用于含有组织切片的玻片上，抗体与目标抗原反应，然后使用显色或萤光染料进行可视化。免疫组织化学有多种类型，包括显色法、萤光和多重法。该技术涉及多个组分，包括一抗和二抗、检测系统和基材。 IHC 具有许多优势，例如高特异性、高灵敏度和能够精确定位细胞组成。它广泛应用于肿瘤学、神经生物学、感染疾病和组织形态发生学等领域。此外，它也应用于法医学、环境研究和药物检测。 IHC 具有成本效益高、速度快、能够处理大量检体等优点。此外，免疫组织化学也以其微创性、原位分析、定量能力以及与自动化技术无缝整合进行高通量筛检等特性而闻名。

日本免疫组织化学市场趋势：

日本老龄化相关疾病（如阿兹海默症和癌症）的日益增多，推动了对免疫组织化学检测的需求，进而促进了市场成长。此外，完善的医疗基础设施为免疫组织化学（IHC）等复杂诊断技术的应用提供了支持，也推动了市场成长。个人化医疗意识的不断提高，也带动了对标靶诊断技术的需求，进一步促进了市场成长。政府对医学研究的投入和支持不断增加，也推动了市场成长。此外，需要早期准确诊断的文明病发病率的上升，也对市场成长产生了积极影响。病理学领域的最新进展，尤其是在组织诊断方面，提升了IHC的重要性，也推动了市场成长。同时，产学研合作的加强，促进了IHC的研发，也推动了市场成长。因此，日本IHC流程自动化程度的提高，减少了人为误差，提高了检测效率，进一步加速了市场成长。此外，免疫组化技术在药物研发和检测中的应用日益广泛，开闢了新的途径，并推动了市场扩张。同时，影像技术的快速发展提高了免疫组化技术的性能，也促进了市场成长。此外，日本医疗费用支出的不断增长，使得先进诊断技术得以应用，这也推动了该国整体市场的成长。

本报告解答的关键问题：

日本免疫组织化学市场目前发展状况如何？未来几年又将如何发展？
新冠疫情对日本免疫组织化学市场产生了哪些影响？
日本免疫组化市场的产品组成是什么？
日本免疫组织化学市场按应用领域分類的市场区隔如何？
日本免疫组织化学市场以最终用户分類的市场组成是什么？
日本免疫组织化学市场价值链的不同阶段有哪些？
日本免疫组织化学市场的主要驱动因素和挑战是什么？
日本免疫组织化学市场的结构是怎么样的？主要参与者有哪些？
日本免疫组织化学市场的竞争程度如何？

Japan immunohistochemistry market size reached USD 188.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 322.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.15% during 2026-2034. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

Antibodies
- Primary Antibodies
- Secondary Antibodies
Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
Reagents
- Histological Stains
- Blocking sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
Kits

Application Insights:

Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
Drug Testing

End User Insights:

Hospitals and Diagnostic Laboratories
Research Institutes
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan immunohistochemistry market?
What is the breakup of the Japan immunohistochemistry market on the basis of product?
What is the breakup of the Japan immunohistochemistry market on the basis of application?
What is the breakup of the Japan immunohistochemistry market on the basis of end user?
What are the various stages in the value chain of the Japan immunohistochemistry market?
What are the key driving factors and challenges in the Japan immunohistochemistry?
What is the structure of the Japan immunohistochemistry market and who are the key players?
What is the degree of competition in the Japan immunohistochemistry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Immunohistochemistry Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Primary Antibodies
  - 6.1.3.2 Secondary Antibodies
- 6.1.4 Market Forecast (2026-2034)
6.2 Equipment
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Slide Staining Systems
  - 6.2.3.2 Tissue Microarrays
  - 6.2.3.3 Tissue Processing Systems
  - 6.2.3.4 Slide Scanners
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2026-2034)
6.3 Reagents
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Histological Stains
  - 6.3.3.2 Blocking sera and Reagents
  - 6.3.3.3 Chromogenic Substrates
  - 6.3.3.4 Fixation Reagents
  - 6.3.3.5 Stabilizers
  - 6.3.3.6 Organic Solvents
  - 6.3.3.7 Proteolytic Enzymes
  - 6.3.3.8 Diluents
- 6.3.4 Market Forecast (2026-2034)
6.4 Kits
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)

7 Japan Immunohistochemistry Market - Breakup by Application

7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Cancer
  - 7.1.3.2 Infectious Diseases
  - 7.1.3.3 Cardiovascular Diseases
  - 7.1.3.4 Autoimmune Diseases
  - 7.1.3.5 Diabetes Mellitus
  - 7.1.3.6 Nephrological Diseases
- 7.1.4 Market Forecast (2026-2034)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Immunohistochemistry Market - Breakup by End User

8.1 Hospitals and Diagnostic Laboratories
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2020-2025)
- 8.3.2 Market Forecast (2026-2034)

9 Japan Immunohistochemistry Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Immunohistochemistry Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Immunohistochemistry Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis

13 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本免疫组织化学市场报告：按产品、应用、最终用户和地区划分（2026-2034年）